ARCHIVES

Atrix, Sanofi In Marketing Deal For Leuprogel Products.

This article is from The Cancer Letter archive.

Vol. 27 No. 04 | January 26, 2001

Download PDF Visit The Full Archive

Related Articles

VEGF Levels Can Predict Tumor’s Resistance to Avastin

July 29, 2011

Intercultural Cancer Council Endorses New NCI Office

July 5, 1996

Scientists, Industry Identify Barriers To Development of Molecular Therapies

April 12, 2002

NCI to Support Research and Development Of Image Guided Therapy for Prostate Cancer

July 16, 1999

NCI/DCT Advisors Approve Concept For $15 Million Lymphoma Studies

June 15, 1990

NCCS Selects New President

October 9, 2009